Goodwin Biotechnology has completed its largest ever round of financing with growth capital to help fund its next stage of expansion. The growth capital will be used to support Goodwin’s investments in doubling its space available for cGMP capacity as it readies for further expansion of its biopharmaceutical manufacturing, including support for commercial product manufacturing and developing various capabilities to better serve its growing customer base.   Goodwin is a full GMP, FDA-regist...